My last encounter with a JK Rowling novel was an abortive attempt to get through a Harry Potter boxed set given to me as a present ten years ago (why […]
Latest articles
Richard Lehman’s journal review—12 November 2012
JAMA 7 Nov 2012 Vol 308 1747 Big trials: don’t you love ‘em? James Penston doesn’t, arguing in his book stats.con (2010) that we have been duped into adopting interventions […]
James Raftery: Breast cancer screening review—would NICE have done it differently?
The publication of a summary of the benefits and harms of breast cancer screening in the Lancet, with the full report to follow, raises the question of whether referring this […]
Desmond O’Neill: The location of Ireland’s new national children’s hospital
One of the hottest topics in Irish medical politics finally came to a head this week with the announcement of the location of the new national childrens’ hospital, amalgamating the […]
Marge Berer and Lisa Hallgarten: Sacrificing the good for the perfect
Post partum haemorrhage (PPH) is one of the leading causes of maternal deaths. According to WHO estimates, in 2010 there were 287,000 maternal deaths, 25% of which were associated with […]
David Payne: Listening to our readers and authors
A year ago today the BMJ’s new website went live. We launched with an explanatory video and a dedicated email address for you, our readers, to provide feedback. This blog is […]
Edward Davies: The American Heart Association and why the world needs journals
You would sometimes be forgiven for thinking that we are now living in the last days of the traditional medical journal. Everything from payment models, to access, and even peer […]
Jennifer McAughey, Sarah Walpole, and Merav Kliner: When generics are more expensive than trade name drugs
Over the last few decades we have become used to the questionable practices of drug companies when profits are at stake. Recent reports on the actions […]
Kasia Malinowska-Sempruch: An opportunity for EU member states to save money and lives
In the coming months, officials will sign the next EU drugs strategy providing a drug policy framework for EU institutions and member states. Past drug strategies have called for a […]
Muir Gray: Choosing criteria for systems of care
Read the rest of this series of blogs about designing and planning population based systems of care here. Step 4: Choosing criteria Choosing criteria is a more time consuming process […]